Pancreatectomy Clinical Trials

12 recruiting

Pancreatectomy Trials at a Glance

15 actively recruiting trials for pancreatectomy are listed on ClinicalTrialsFinder across 6 cities in 15 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Oslo, Clichy, and Amsterdam. Lead sponsors running pancreatectomy studies include Assistance Publique - Hôpitaux de Paris, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), and Casa di Cura Dott. Pederzoli.

Browse pancreatectomy trials by phase

Treatments under study

About Pancreatectomy Clinical Trials

Looking for clinical trials for Pancreatectomy? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Pancreatectomy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Pancreatectomy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 115 of 15 trials

Recruiting
Not Applicable

Patients With Pancreatic Tumor: Use of an App to Monitor Progress in a Simple and Intuitive Way by Periodically Completing Targeted Questionnaires and Providing Educational and Informational Content.

Pain ManagementCaregiverPancreatectomy+3 more
Casa di Cura Dott. Pederzoli185 enrolled2 locationsNCT07532590
Recruiting
Not Applicable

Utility of Trypsinogen -2 in Early Detection and Follow Up of Post-pancreatectomy Acute Pancreatitis (PPAP)

PancreatitisPancreatectomy
Indiana University50 enrolled1 locationNCT06903676
Recruiting
Phase 3

Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?

PancreatectomyPancreas NeoplasmCyst of Pancreas
Case Comprehensive Cancer Center234 enrolled1 locationNCT05720338
Recruiting

Incidence and Clinical Impact of Serum Hyperamylasemia (POH) After Pancreatectomy on Postoperative Outcome and Patient Safety

PancreatectomyPancreatitis, AcuteHyperamylasemia
Technische Universität Dresden150 enrolled1 locationNCT06126601
Recruiting
Not Applicable

Pancreaticoduodenectomies With Complete Arterial Coverage by Retromesenteric Omentoplasty

Complication of Surgical ProcedurePancreatectomy
Assistance Publique - Hôpitaux de Paris150 enrolled1 locationNCT05992857
Recruiting
Not Applicable

Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3)

SurgeryPancreatic NeoplasmsPancreatic Cyst+7 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)256 enrolled1 locationNCT06939023
Recruiting

Oncological Safety of Spleen Preservation in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID)

Pancreatic Cancer ResectablePancreatectomy
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)94 enrolled10 locationsNCT07157605
Recruiting
Not Applicable

Effects of Peptamen 1.6 in Malnourished Patients (or at Risk) With Pancreatic Neoplasia Undergoing Cephalic Pancreaticoduodenectomy (CPD): A Mechanistic Study

Pancreatic Cancer, AdultCephalic Duodenopancreatectomy
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud20 enrolled1 locationNCT06852014
Recruiting

A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer

Chemotherapy EffectLocally Advanced Pancreatic CancerPancreatectomy+1 more
Oslo University Hospital400 enrolled5 locationsNCT06944587
Recruiting

Effect of an Enhanced Recovery After Surgery Program on Outcomes After Pancreatoduodenectomy

Enhanced Recovery After SurgeryPancreatic Cancer ResectablePancreatectomy
University of Thessaly170 enrolled1 locationNCT06935448
Recruiting
Phase 3

Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC

SurgeryPancreas CancerNeoadjuvant Chemotherapy+3 more
Sahlgrenska University Hospital432 enrolled1 locationNCT06714604
Recruiting
Not Applicable

Intrapapillary Botulinum Toxin Injection for PREvention of Post-surgical PAncREactic Fistula

Postoperative Pancreatic FistulaDistal Pancreatectomy
Assistance Publique - Hôpitaux de Paris460 enrolled1 locationNCT04220931
Recruiting

Management of Traumatic Pancreas Transection

Pancreatectomy
National Cheng-Kung University Hospital50 enrolled1 locationNCT05856474
Recruiting
Not Applicable

Preoperative Endoscopic Pancreatic Stent for Distal Pancreatectomy

PancreatectomyPancreatic Fistula
Chinese University of Hong Kong56 enrolled1 locationNCT05297136
Recruiting

MS1819-SD phase IIa clinical trial for patients with exocrine pancreatic insufficiency (EPI) caused by chronic pancreatitis (CP) and/or distal pancreatectomy.

Exocrine pancreatic insufficiency (EPI) caused by chronic pancreatitis (CP)Exocrine pancreatic insufficiency (EPI) caused by distal pancreatectomy.
INC Research Australia Pty Ltd13 enrolled6 locationsACTRN12616000962437